XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2021 $ 1,307,704 $ 140 $ 368,595 $ (263) $ 1,194 $ 702,759 $ 235,279
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 151,883         122,056 29,827
Other comprehensive income 12,919       12,919    
Amounts reclassified from Accumulated other comprehensive income 1,737       1,737    
Contributions from noncontrolling interests 2,450           2,450
Distributions to noncontrolling interests (34,930)           (34,930)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 10,719 2 13,079 (2,362)      
Purchase of treasury shares (7,701)     (7,701)      
Dividends declared per common share (18,240)         (18,240)  
Restricted share award dividend equivalents 0   54 335   (389)  
Ending Balance at Sep. 30, 2022 1,426,541 142 381,728 (9,991) 15,850 806,186 232,626
Beginning Balance at Jun. 30, 2022 1,417,206 142 378,740 (2,313) 15,090 775,495 250,052
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 44,272         36,748 7,524
Other comprehensive income 1,198       1,198    
Amounts reclassified from Accumulated other comprehensive income (438)       (438)    
Distributions to noncontrolling interests (24,950)           (24,950)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 3,011   2,988 23      
Purchase of treasury shares (7,701)     (7,701)      
Dividends declared per common share (6,057)         (6,057)  
Restricted share award dividend equivalents 0            
Ending Balance at Sep. 30, 2022 1,426,541 142 381,728 (9,991) 15,850 806,186 232,626
Beginning Balance at Dec. 31, 2022 1,429,769 142 385,248 (15,043) 20,484 807,770 231,168
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 54,092         50,004 4,088
Other comprehensive income 16,133       16,133    
Amounts reclassified from Accumulated other comprehensive income (8,038)       (8,038)    
Distributions to noncontrolling interests (44,304)           (44,304)
Deconsolidation of joint venture 17,399           17,399
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 4,213   (2,146) 6,359      
Purchase of treasury shares (1,747)     (1,747)      
Dividends declared per common share (18,728)         (18,728)  
Restricted share award dividend equivalents 297   622 165   (490)  
Ending Balance at Sep. 30, 2023 1,449,086 142 383,724 (10,266) 28,579 838,556 208,351
Beginning Balance at Jun. 30, 2023 1,438,482 142 380,376 (10,270) 25,482 835,256 207,496
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 30,523         9,708 20,815
Other comprehensive income 6,060       6,060    
Amounts reclassified from Accumulated other comprehensive income (2,963)       (2,963)    
Distributions to noncontrolling interests (19,960)           (19,960)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 3,352   3,348 4      
Dividends declared per common share (6,243)         (6,243)  
Restricted share award dividend equivalents (165)         (165)  
Ending Balance at Sep. 30, 2023 $ 1,449,086 $ 142 $ 383,724 $ (10,266) $ 28,579 $ 838,556 $ 208,351